shares in shield therapeutics plc rose thursday after it said that it had secured agreements to expand its patient access in the us for its accrufer product the londonlisted pharmaceutical company said the agreements provide it with access to around 40 million commercial patients in the us shares in the company at 0914 gmt were up 775 pence or 27 at 37 pence